233 related articles for article (PubMed ID: 12957377)
1. Engineering of RNase P ribozyme for gene-targeting applications.
Raj SM; Liu F
Gene; 2003 Aug; 313():59-69. PubMed ID: 12957377
[TBL] [Abstract][Full Text] [Related]
2. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
Trang P; Kim K; Liu F
Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
[TBL] [Abstract][Full Text] [Related]
3. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture.
Kilani AF; Trang P; Jo S; Hsu A; Kim J; Nepomuceno E; Liou K; Liu F
J Biol Chem; 2000 Apr; 275(14):10611-22. PubMed ID: 10744757
[TBL] [Abstract][Full Text] [Related]
4. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.
Kim K; Liu F
Biochim Biophys Acta; 2007; 1769(11-12):603-12. PubMed ID: 17976837
[TBL] [Abstract][Full Text] [Related]
6. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate.
Trang P; Hsu AW; Liu F
Nucleic Acids Res; 1999 Dec; 27(23):4590-7. PubMed ID: 10556315
[TBL] [Abstract][Full Text] [Related]
7. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.
Trang P; Kim K; Zhu J; Liu F
J Mol Biol; 2003 May; 328(5):1123-35. PubMed ID: 12729746
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of the protein cofactor on the interactions between an RNase P ribozyme and its target mRNA substrate.
Hsu AW; Kilani AF; Liou K; Lee J; Liu F
Nucleic Acids Res; 2000 Aug; 28(16):3105-16. PubMed ID: 10931926
[TBL] [Abstract][Full Text] [Related]
9. General design and construction of RNase P ribozymes for gene-targeting applications.
Zou H; Chan K; Trang P; Liu F
Methods Mol Biol; 2004; 252():385-98. PubMed ID: 15017065
[TBL] [Abstract][Full Text] [Related]
10. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
Trang P; Kilani A; Lee J; Hsu A; Liou K; Kim J; Nassi A; Kim K; Liu F
J Clin Virol; 2002 Aug; 25 Suppl 2():S63-74. PubMed ID: 12361758
[TBL] [Abstract][Full Text] [Related]
11. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1.
Trang P; Kilani A; Kim J; Liu F
J Mol Biol; 2000 Aug; 301(4):817-26. PubMed ID: 10966788
[TBL] [Abstract][Full Text] [Related]
12. UV cross-link mapping of the substrate-binding site of an RNase P ribozyme to a target mRNA sequence.
Kilani AF; Liu F
RNA; 1999 Sep; 5(9):1235-47. PubMed ID: 10496224
[TBL] [Abstract][Full Text] [Related]
13. In vitro selection of RNase P ribozymes that efficiently cleave a target mRNA.
Kim K; Liu F
Methods Mol Biol; 2004; 252():399-412. PubMed ID: 15017066
[TBL] [Abstract][Full Text] [Related]
14. Mapping the regions of RNase P catalytic RNA that are potentially in close contact with its protein cofactor.
Trang P; Liu F
Methods Mol Biol; 2008; 488():267-77. PubMed ID: 18982298
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of novel catalytic activity by the M1 RNA ribozyme: the cost of molecular adaptation.
Cole KB; Dorit RL
J Mol Biol; 1999 Oct; 292(4):931-44. PubMed ID: 10525416
[TBL] [Abstract][Full Text] [Related]
16. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
Zhang W; Li X; Luo G; Huang Z; Liu Y
Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280
[TBL] [Abstract][Full Text] [Related]
17. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme.
Trang P; Lee J; Kilani AF; Kim J; Liu F
Nucleic Acids Res; 2001 Dec; 29(24):5071-8. PubMed ID: 11812839
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hepatitis C virus by an M1GS ribozyme derived from the catalytic RNA subunit of Escherichia coli RNase P.
Mao X; Li X; Mao X; Huang Z; Zhang C; Zhang W; Wu J; Li G
Virol J; 2014 May; 11():86. PubMed ID: 24885776
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Amplification and Selection of Engineered RNase P Ribozyme for Gene Targeting Applications.
Trang P; Zhang I; Liu F
Methods Mol Biol; 2024; 2822():419-429. PubMed ID: 38907932
[TBL] [Abstract][Full Text] [Related]
20. Mapping of RNase P Ribozyme Regions in Proximity with a Human RNase P Subunit Protein Using Fe(II)-EDTA Cleavage and Nuclease Footprint Analyses.
Trang P; Smith A; Liu F
Methods Mol Biol; 2023; 2666():55-67. PubMed ID: 37166656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
